Pro-Dex Inc. Common Stock (PDEX)
Stock · NASDAQ · Health Care
$58.26as of 10/16/2026
Price chart
Active signals
PDEX Signal Track Record
How signals performed across all stocks →What PDEX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| 200-Day Moving Average TouchActive now | 26 | -0.3% | 46% | February 17, 2026 |
| Volume Spike | 22 | +3.3% | 55% | September 4, 2026 |
| Bollinger Band Breakdown | 20 | +1.7% | 60% | August 31, 2026 |
| Bollinger Band Breakout | 19 | +6.3% | 63% | September 4, 2026 |
| Any 20-session window (baseline) | +1.7% | 56% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PDEX
Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting service…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 201
- Website
- www.pro-dex.com/
Fundamentals
- 1-day range
- $58.25$59.51
- Market cap
- $209.06M
- P/E (trailing)
- 14.11
- P/E (forward)
- 17.44
- EPS (trailing)
- $4.12
- Dividend yield
- —
- Beta
- 0.09
- Avg. volume
- 73.3K
How Pro-Dex Inc. Common Stock Makes Money
Where the revenue actually goes — FY2026 annual results
Source: 10-K filed Sep 3, 2026 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
Pro-Dex Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PDEXPro-Dex Inc. Common Stock$58.26▼ 2.93%Market cap $209.06MP/E 14.11$23.47$77
- EMBCEmbecta Corp. Common Stock$6.27▼ 2.79%Market cap $207.65MP/E 4.00$2.77$14.91
- SENSSenseonics Holdings Inc. Common Stock$7.77▼ 5.59%Market cap $215.29MP/E —$4.79$10.64
- LUCDLucid Diagnostics Inc. Common Stock$0.478▼ 8.08%Market cap $193.54MP/E —$0.5$1.63
- INFUInfuSystems Holdings Inc. Common Stock$13.4▼ 3.74%Market cap $236.42MP/E 31.71$7.29$13.85
- APYXApyx Medical Corporation Common Stock$2.55▼ 0.39%Market cap $174.35MP/E —$2.32$5.08
- KRMDKORU Medical Systems Inc. Common Stock (DE)$3▼ 0.99%Market cap $163.52MP/E —$2.86$6.61
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PDEX Pro-Dex Inc. Common Stock | $209.06M | 14.11 | $58.26 | ▼ 2.93% | $23.47$77 |
| EMBC Embecta Corp. Common Stock | $207.65M | 4.00 | $6.27 | ▼ 2.79% | $2.77$14.91 |
| SENS Senseonics Holdings Inc. Common Stock | $215.29M | — | $7.77 | ▼ 5.59% | $4.79$10.64 |
| LUCD Lucid Diagnostics Inc. Common Stock | $193.54M | — | $0.478 | ▼ 8.08% | $0.5$1.63 |
| INFU InfuSystems Holdings Inc. Common Stock | $236.42M | 31.71 | $13.4 | ▼ 3.74% | $7.29$13.85 |
| APYX Apyx Medical Corporation Common Stock | $174.35M | — | $2.55 | ▼ 0.39% | $2.32$5.08 |
| KRMD KORU Medical Systems Inc. Common Stock (DE) | $163.52M | — | $3 | ▼ 0.99% | $2.86$6.61 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDexYahoo · 10/2/2026
- 5 Medical Dental Supply Stocks to Watch as Industry Prospects ImproveYahoo · 10/1/2026
- Best Momentum Stocks to Buy for September 18thYahoo · 9/18/2026
- New Strong Buy Stocks for September 18thYahoo · 9/18/2026
Insider Activity
Insider Actions →- Van Kirk Richard Lee Jr · September 11, 2026 · Sale475 @ $59.62
- Van Kirk Richard Lee Jr · September 11, 2026 · Sale290 @ $58.94
- Van Kirk Richard Lee Jr · September 9, 2026 · Sale4.8K @ $59.45
- Van Kirk Richard Lee Jr · September 9, 2026 · Sale806 @ $58.66
- Van Kirk Richard Lee Jr · September 9, 2026 · Sale300 @ $64.7
- Van Kirk Richard Lee Jr · September 9, 2026 · Sale2.1K @ $63.85
- Van Kirk Richard Lee Jr · September 9, 2026 · Sale935 @ $62.93
- Van Kirk Richard Lee Jr · September 9, 2026 · Sale1.2K @ $61.88
- Van Kirk Richard Lee Jr · September 9, 2026 · Sale4.3K @ $60.72
- Van Kirk Richard Lee Jr · September 9, 2026 · Sale2.7K @ $59.84
- Van Kirk Richard Lee Jr · September 9, 2026 · Sale2.2K @ $58.92
- Alisha Charlton · September 9, 2026 · Sale800 @ $61.76
- Alisha Charlton · September 9, 2026 · Sale1.5K @ $61.05
- Angelita Rebamontan Domingo · July 23, 2026 · Grant19 @ $33.25
- Angelita Rebamontan Domingo · July 1, 2026 · Tax Withholding2.5K @ $62.74
Institutional Ownership
March 31, 2026
- Total shares held
- 689.5K
- Total value held
- $33.83M
- Institutional holders
- 54
- Unknown152.5K
- Unknown111.3K
- Unknown61.7K
- Unknown56.9K
- Unknown48.3K
- Unknown46.7K
- Unknown33.1K
- Unknown15.0K
- Unknown14.2K
- Unknown13.2K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
PDEX Featured in Industry Outlook on Dental Supply Stocks
PDEX was named in a Yahoo article that lists five dental supply stocks to watch as the industry looks to improve. The piece notes rising demand for dental products and services, which could benefit companies like PDEX that supply medical and dental equipment. The article reflects broader optimism in the sector, though it does not provide specific price guidance for PDEX.
PDEX Featured in Industry Outlook on Dental Supply Stocks. PDEX was named in a Yahoo article that lists five dental supply stocks to watch as the industry looks to improve. The piece notes rising demand for dental products and services, which could benefit companies like PDEX that supply medical and dental equipment. The article reflects broader optimism in the sector, though it does not provide specific price guidance for PDEX.